The claim that a specific APOA2 variant directly causes fatigue is not supported by strong evidence. APOA2 encodes apolipoprotein A-II, a component of HDL cholesterol. Some studies have linked APOA2 polymorphisms (e.g., rs5082) to altered lipid metabolism or BMI, but a causal relationship with fatigue or tiredness has not been established. Fatigue is multifactorial—sleep, stress, diet, exercise, hormones—and a single gene contributes minimally. Evidence is weak to moderate (association studies, no clinical endpoints). A DNA test for APOA2 to predict or manage fatigue is not clinically useful. Focus on proven lifestyle factors instead. Caveat: No clinical validation for fatigue as an endpoint.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-152df0b7a9764b66de9266e7